Health

Zymergen Appoints Global Finance Expert Enakshi Singh as Chief Financial Officer

EMERYVILLE, Calif., Feb. 24, 2021 /PRNewswire/ -- Biofacturing leader Zymergen  today announced it has promotedEnakshi (Ena) Singh to Chief Financial Officer. Singh has helped Zymergen close more than$1B in equity financing and $100M in debt since joining Zymergen as vice president of finance in 2...

2021-02-24 22:30 5698

VLP BioTech, Inc. Announces an Immunotherapy Designed for the Treatment of Chronic HBV/HDV Infections

-  VLP BioTech Has Developed a Vaccine-Based Viral-Entry-Inhibitor for the Treatment of Chronic HBV/HDV. -  The Vaccine-Based Treatment Has Significant Advantages Compared to a Peptide-Based, Entry-Inhibitor (Hepcludex). SAN DIEGO, Feb. 24, 2021 /PRNewswire/ -- VLP BioTech, Inc., a private, pre...

2021-02-24 22:00 3602

Occlutech announces Completion of Patient Enrolment in Pilot Study of Atrial Flow Regulator (AFR) in Patients with Heart Failure

SCHAFFHAUSEN, Switzerland, Feb. 24, 2021 /PRNewswire/ -- Occlutech, a privately-held company, announced today the completion of patient enrolment in its pilot study to assess safety and efficacy of the novel Atrial Flow Regulator (AFR) in heart failure (HF) patients (PRELIEVE trial). PRELIEVE is...

2021-02-24 20:41 2730

MedTech to Take Advantage of Digital Health Platform as a Service Model to Accelerate Digital Transformation across the Healthcare Industry

A proven, compliant platform can expedite market entry and optimize time and effort without building competencies internally, finds Frost & Sullivan SANTA CLARA, Calif., Feb. 24, 2021 /PRNewswire/ -- MedTech and Life Sciences companies are transitioning beyondbiopharmaceuticals, medical devices, ...

2021-02-24 20:02 2217

Advanced Aesthetic Technologies, Inc.'s Algeness® Chosen as a Top Finalist in Prestigious Terra2 Solution Skin Health Innovation Competition

BROOKLINE, Mass., Feb. 24, 2021 /PRNewswire/ -- Advanced Aesthetic Technologies, Inc. (AAT), a leader in aesthetic gel implant technology, is proud to announce that AAT and our lead product Algeness® were selected as one of the top two finalists in the recent Terra2 Solutions Skin Health Innovati...

2021-02-24 19:00 3893

Mohamed bin Zayed University of Artificial Intelligence and Weizmann Institute of Science establish joint AI Program

- New collaborative projects will facilitate joint research projects, training programs, conferences, student exchange programs and more ABU DHABI, UAE, Feb. 24, 2021 /PRNewswire/ -- The Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) and the Weizmann Institute of Science (WIS) ...

2021-02-24 16:28 4296

INOVIO and QIAGEN expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO's VGX-3100 for advanced cervical dysplasia

- Liquid biopsy-based precision test guides patient selection and offers potential for cost-effective, non-invasive alternative to surgical removal of cervical lesions - QIAGEN's bioinformatic expertise raises predictive biomarker power in INOVIO's patient selection - First-in-class next genera...

2021-02-24 14:45 6741

Additional Positive Interim Results from Nanoform's Clinical Study

HELSINKI, Feb. 24, 2021 /PRNewswire/ -- Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, today announced further positive interim results from its ongoing clinical study. The fast absorption data implies that small is powerful® and might offer viable alternatives to com...

2021-02-24 14:33 1483

Antengene Announces NDA for ATG-010 (Selinexor) Granted Priority Review by China's NMPA

SHANGHAI and HONG KONG, Feb. 24, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and onco...

2021-02-24 08:00 4507

US Court Grants MGI's Motion to Amend in Suit Against Illumina

SAN FRANCISCO, Feb. 24, 2021 /PRNewswire/ -- A judge in the U.S. District Court for the Northern District ofCalifornia has granted MGI's motion for leave to amend to add a new inequitable conduct defense of patent infringement lawsuit that Illumina filed against MGI inFebruary 2020 (Case No. 20-c...

2021-02-24 04:00 4161

New Research Highlights the Potential of Transforming Healthcare with Mobile EEG Brain Health Assessments

Recent publications in Frontiers of Neuroscience, Scientific Report and Neurophysiologie Clinique validate the use of Muse® as a mobile EEG device to measure brain health and performance at scale in real-world environments TORONTO, Feb. 24, 2021 /PRNewswire/ -- In a time with overburdened healthc...

2021-02-24 03:21 1816

Skybox Security Announces 2020 Partner Awards

Channel and distributor partners recognized for commitment to customer excellence and performance SAN JOSE, Calif., Feb. 23, 2021 /PRNewswire/ -- Skybox Security, a global leader in security posture management, today announced the winners of its 2020 Partner Awards. The inaugural award program r...

2021-02-23 22:05 2704

Rheumatology Clinical Researcher Professor David Hunter Joins George Clinical Scientific Leadership

OVERLAND PARK, Kan., Feb. 23, 2021 /PRNewswire/ -- David Hunter, MBBS, PhD, a renowned clinical researcher and rheumatology expert based inAustralia, has joined the scientific leadership of George Clinical, a global scientifically-backed clinical research organization. Professor Hunter's researc...

2021-02-23 22:00 1694

ScImage Lauded by Frost & Sullivan for Its Cloud-based Enterprise Imaging Platform, PICOM365

Its seamless integration across imaging programs and tools give physicians single-platform access to all the tools needed to view and interpret images and videos from anywhere SANTA CLARA, Calif., Feb. 23, 2021 /PRNewswire/ -- Based on its recent analysis of the North American cloud-based enterp...

2021-02-23 22:00 1813

INOVIO Announces First Subject Dosed in Phase 1B Clinical Trial for its DNA Vaccine Against Lassa Fever, INO-4500, in West Africa

Phase 1B clinical trial is first study for Lassa fever conducted in Africa Goal is for vaccine to be available for emergency use as stockpile product following Phase 2 Progress on INO-4500 reflects INOVIO's focus on and continued commitment to the fight against infectious diseases Trial fully f...

2021-02-23 21:00 5631

Inovalon Lauded by Frost & Sullivan for Continuously Advancing Data-Driven Healthcare with Its Cloud-Based Inovalon ONE® Platform

Inovalon combines industry interconnectivity, large-scale, comprehensive data assets, and analytics with subject matter expertise to support clients strategically SANTA CLARA, Calif., Feb. 23, 2021 /PRNewswire/ -- Based on its recent analysis of the North American healthcare and life sciences an...

2021-02-23 21:00 5231

RedHill Biopharma Announces Planned Expansion of Opaganib Global Phase 2/3 COVID-19 Study to the U.S.

TEL AVIV, Israel and RALEIGH, NC, Feb. 23, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced its plans to expand the Company's global Phase 2/3 study of opaganib[1] ...

2021-02-23 20:33 4699

Barco Applauded by Frost & Sullivan for its Continued Domination of the Wireless Content Sharing Market

Its successful ClickShare product line, wide footprint, and strong technology partnership have helped it maintain its competitive edge SANTA CLARA, Calif., Feb. 23, 2021 /PRNewswire/ -- Based on its recent analysis of the global stand-alone wireless content sharing market,Frost & Sullivan recogn...

2021-02-23 20:17 1555

For third year straight, Elekta named one of the world's most ethical companies by Ethisphere

STOCKHOLM, Feb. 23, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has again been recognized as one of theWorld's Most Ethical Companies®  by the Ethisphere Institute, a global leader in defining and advancing the standards of ethical business practices. The honor is bestowed upo...

2021-02-23 20:02 3670

Kira Pharmaceuticals Expands Executive Leadership Team with Chief Business Officer, Chief Medical Officer and Chief Commercial Officer, China

CAMBRIDGE, Mass. and SUZHOU, China, Feb. 23, 2021 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases, today announced the addition of three seasoned pharmaceutical leaders,Kathy He, R...

2021-02-23 20:00 4200
1 ... 536537538539540541542 ... 560

Week's Top Stories